Explore the latest Johns Hopkins Drug Access and Affordability Initiative (JHDAAI) research on Anti Competitive Practices which includes: the Orphan Drug Act, Pharmaceutical Benefit Managers, Single Source Generic Drugs, and more.
Policies to Improve Access to Medicines
Explore the latest JHDAAI research on Policies to Improve Access to Medicines which includes: Addressing Price Gouging, Hepatitis C in Louisiana, Incorporating Drugs into Bundled Payments and ACOs, and more.
Federal Pharmaceutical Spending
Explore the latest JHDAAI research on Federal Pharmaceutical Spending which includes: Part D Catastrophic Coverage, Drug Formulary Differences, Drug Prices Paid by Federal Agencies, and more.
Pharmaceutical Pricing Fairness
Explore the latest JHDAAI research on Pharmaceutical Pricing Fairness which includes: Understanding and Assessing Fairness in the Branded Prescription Drug Market, and more.
To see more of the latest research on the factors impacting drug affordability and access, browse additional sources whose work the Johns Hopkins Drug Access and Affordability Initiative (JHDAAI) trusts.
The Johns Hopkins Drug Access and Affordability Initiative (JHDAAI) regularly publishes “Chartbooks” as a handy, graphical and frequently-updated reference created to provide an overview of our research and data outcomes.